Patents by Inventor Hironori Yuyama

Hironori Yuyama has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING STRESS URINARY INCONTINENCE OR MIXED URINARY INCONTINENCE, AND METHOD FOR SCREENING COMPOUND COMPRISED IN SAID PHARMACEUTICAL COMPOSITION
    Publication number: 20150368220
    Abstract: [Problem ] To provide a pharmaceutical composition for treating or preventing urinary incontinence on the basis of a novel mechanism of action, and a method for screening a compound to be comprised in the pharmaceutical composition as an active ingredient. [Means for Solution] The present invention relates to a pharmaceutical composition for treating or preventing stress urinary incontinence or mixed urinary incontinence, comprising a compound having a melatonin receptor activation action as an active ingredient. Examples of the active ingredient include melatonin, ramelteon, agomelatine, tasimelteon, TIK-301, and the like.
    Type: Application
    Filed: July 9, 2013
    Publication date: December 24, 2015
    Applicant: Astellas Pharma Inc.
    Inventors: Toru Watanabe, Keiko Kawabata, Yuka Watanabe, Hironori Yuyama, Noriyuki Masuda, Edward C. Burgard, Karl Bruce Thor
  • Remedies for endothelin-induced diseases
    Patent number: 6774131
    Abstract: A pharmaceutical composition for therapeutically treating prostate cancer, the pharmaceutical composition containing N-[6-methoxy-5-(2-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyri midinyl]-2-phenylethenesulfoneamide or a pharmaceutically acceptable salt thereof as the effective component.
    Type: Grant
    Filed: July 19, 2002
    Date of Patent: August 10, 2004
    Assignee: Yamanouchi Pharmaceutical Co., Ltd.
    Inventors: Hironori Yuyama, Akira Fujimori, Masanao Sanagi, Hironori Harada, Akiko Koakutsu, Mikiko Mori, Nobuyuki Yamamoto
  • Novel use of arylethenesulfonamide derivative
    Publication number: 20040138241
    Abstract: Novel use of N-[6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)-pyrimidin-4-yl]-2-phenylethenesulfonamide or a pharmaceutically acceptable salt thereof That is, a pharmaceutical composition for remedy of dysuria containing N-[6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)-pyrimidin-4-yl]-2-phenylethenesulfonamide or a pharmaceutically acceptable salt thereof as an active ingredient.
    Type: Application
    Filed: October 10, 2003
    Publication date: July 15, 2004
    Inventors: Akira Fujimori, Hironori Yuyama, Masanao Sanagi, Akiko Koakutsu, Nobuyuki Yamamoto
  • Novel use of arylethene sulfonamide derivative
    Publication number: 20040097529
    Abstract: Novel use of N-[6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl]-2-phenylethenesulfonamide or a pharmaceutically acceptable salt thereof. Improvement of the following particular condition in a diabetic patient: (1) Elevation of blood glucose level; (2) Elevation of blood lipid level after the onset of early-stage nephropathy; (3) Renal dysfunction after the onset of early-stage nephropathy; (4) Increase of urinary albumin excretion after the onset of early-stage nephropathy; (5) Glomerular hyperfiltration after the onset of early-stage nephropathy; (6) Renal dysfunction after the progress toward chronic renal failure; (7) Increase of urinary protein excretion after the progress toward chronic renal failure.
    Type: Application
    Filed: September 26, 2003
    Publication date: May 20, 2004
    Inventors: Akira Fujimori, Hironori Yuyama, Atsuo Tahara, Rie Sonoda, Kumiko Shibasaki
  • Medicinal composition for treatment of chronic cardiac failure
    Publication number: 20040058943
    Abstract: A pharmaceutical composition for ameliorating exercise tolerance depression of cases of chronic heart failure, which contains, as the active ingredient, N-[6-methoxy-5-(2-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrim idinyl]-2-phenylethenesulfonamide or its pharmaceutically-acceptable salt thereof as the active ingredient.
    Type: Application
    Filed: July 30, 2003
    Publication date: March 25, 2004
    Inventors: Akira Fujimori, Hironori Yuyama, Hironori Harada